In a significant step toward ensuring global quality standards, Indian pharmaceutical, nutraceutical, and medical device ...

On December 16, 2024, the SEC announced settled charges against Becton, Dickinson and Company for misleading investors about risks associated with ...

As we ring in the new year, it is time, once again, to reflect on some of the most significant legal developments for drug and device companies ...